conducts activities across drug commercialization, regulatory management, clinical development, and patient support services for rare disease communities. Catalyst Pharmaceuticals also manages licensing and collaboration agreements related to specialty pharmaceutical products and orphan drug therapies. Its operations include medical affairs, pharmacovigilance, and programs that support patient access, reimbursement navigation, and treatment continuity.